Simultaneous exposure of rats to dioxin and carbon monoxide reduces the xenobiotic but not the hypoxic response

Biological Chemistry

Volumn 385, Issue 3-4, 2004, Pages 291-294

  Hofer, Thomas ^a   Phojanvirta, Raimo ^b,d   Spielmann, Patrick ^a   Viluksela, Matti ^c   Buchmann, David P ^a   Wenger, Roland H ^a   Gassmann, Max ^a  

^a UNIVERSITY OF ZURICH   (Switzerland)

^b ACADEMY OF FINLAND   (Finland)

^c NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^d UNIVERSITY OF HELSINKI   (Finland)

Author keywords

Aryl hydrocarbon receptor; Cytochrome P450; Erythropoietin; Hypoxia inducible factor 1; Vascular endothelial growth factor

Indexed keywords

2,3,7,8 TETRACHLORODIBENZO PARA DIOXIN; AROMATIC HYDROCARBON RECEPTOR; CARBON MONOXIDE; CARRIER PROTEIN; DIOXIN; HYPOXIA INDUCIBLE FACTOR 1ALPHA; TRANSCRIPTION FACTOR; XENOBIOTIC AGENT;

ANEMIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COMPLEX FORMATION; CONTROLLED STUDY; EXPOSURE; GENETIC TRANSCRIPTION; HYPOXIA; IN VIVO STUDY; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; TRANSACTIVATION;

ANIMALS; ANOXIA; BRAIN; CARBON MONOXIDE; DIOXINS; LIVER; MALE; RATS; RATS, LONG-EVANS; RNA, MESSENGER; TETRACHLORODIBENZODIOXIN; XENOBIOTICS;

EID: 2542449969     PISSN: 14316730     EISSN: None     Source Type: Journal    
DOI: 10.1515/BC.2004.024     Document Type: Article

References (41)

1. Carver, L.A., Jackiw, V., and Bradfield, C.A. (1994). The 90-kDa heat shock protein is essential for Ah receptor signaling in a yeast expression system. J. Biol. Chem. 269, 30109-30112.
2. Chan, W.K., Yao, G., Gu, Y.Z., and Bradfield, C.A. (1999). Crosstalk between the aryl hydrocarbon receptor and hypoxia inducible factor signaling pathways. Demonstration of competition and compensation. J. Biol. Chem. 274, 12115-12123.
3. Chilov, D., Camenisch, G., Kvietikova, I., Ziegler, U., Gassmann, M., and Wenger, R.H. (1999). Induction and nuclear translocation of hypoxia-inducible factor-1 (HIF-1): heterodimerization with ARNT is not necessary for nuclear accumulation of HIF-1α. J. Cell Sci. 112, 1203-1212.
4. Cockman, M.E., Masson, N., Mole, D.R., Jaakkola, P., Chang, G.W., Clifford, S.C., Maher, E.R., Pugh, C.W., Ratcliffe, P.J., and Maxwell, P.H. (2000). Hypoxia inducible factor-α binding and ubiquitylation by the von Hippel-Lindau tumor suppressor protein. J. Biol. Chem. 275, 25733-25741.
5. Conney, A.H. (1982). Induction of microsomal enzymes by foreign chemicals and carcinogenesis by polycyclic aromatic hydrocarbons: G. H. A. Clowes Memorial Lecture. Cancer Res. 42, 4875-4917.
6. Gassmann, M., and Wenger, R.H. (1997). HIF-1, a mediator of the molecular response to hypoxia. News Physiol. Sci. 12, 214-218.
7. Gassmann, M., Kvietikova, I., Rolfs, A., and Wenger, R.H. (1997). Oxygen- and dioxin-regulated gene expression in mouse hepatoma cells. Kidney Int. 51, 567-574.
8. Gonzalez, F.J., Fernandez-Salguero, P., and Ward, J.M. (1996). The role of the aryl hydrocarbon receptor in animal development, physiological homeostasis and toxicity of TCDD. J. Toxicol. Sci. 21, 273-277.
9. Gradin, K., McGuire, J., Wenger, R.H., Kvietikova, I., Whitelaw, M.L., Toftgård, R., Tora, L., Gassmann, M., and Poellinger, L. (1996). Functional interference between hypoxia and dioxin signal transduction pathways: competition for recruitment of the Arnt transcription factor. Mol. Cell. Biol. 16, 5221-5231.
10. Gu, Y.Z., Hogenesch, J.B., and Bradfield, C.A. (2000). The PAS superfamily: sensors of environmental and developmental signals. Annu. Rev. Pharmacol. Toxicol. 40, 519-561.
11. Hankinson, O. (1995). The aryl hydrocarbon receptor complex. Annu. Rev. Pharmacol. Toxicol. 35, 307-340.
12. Ho, V.T., and Bunn, H.F. (1996). Effects of transition metals on the expression of the erythropoietin gene: further evidence that the oxygen sensor is a heme protein. Biochem. Biophys. Res. Commun. 223, 175-180.
13. Hofer, T., Desbaillets, I., Höpfl, G., Gassmann, M., and Wenger, R.H. (2001). Dissecting hypoxia-dependent and hypoxia-independent steps in the HIF-1α activation cascade: implications for HIF-1α gene therapy. Faseb J. 15, 2715-2717.
14. Hofer, T., Desbaillets, I., Höpfl, G., Wenger, R.H., and Gassmann, M. (2002). Characterization of HIF-1α overexpressing HeLa cells and implications for gene therapy. Comp. Biochem. Phys. 133, 475-481.
15. Höpfl, G., Ogunshola, O., and Gassmann, M. (2004). HIFs and tumors - causes and consequences. Am. J. Physiol. 286, R608-R623.
16. 2-dependent degradation domain via the ubiquitin-proteasome pathway. Proc. Natl. Acad. Sci. USA 95, 7987-7992.
17. Jewell, U.R., Kvietikova, I., Scheid, A., Bauer, C., Wenger, R.H., and Gassmann, M. (2001). Induction of HIF-1α in response to hypoxia is instantaneous. FASEB J. 15, 1312-1314.
18. Kallio, P.J., Wilson, W.J., S, O.B., Makino, Y., and Poellinger, L. (1999). Regulation of the hypoxia-inducible transcription factor 1α by the ubiquitin-proteasome pathway. J. Biol. Chem. 274, 6519-6525.
19. Kamura, T., Sato, S., Iwai, K., Czyzyk-Krzeska, M., Conaway, R.C., and Conaway, J.W. (2000). Activation of HIF1α ubiquitination by a reconstituted von Hippel-Lindau (VHL) tumor suppressor complex. Proc. Natl. Acad. Sci. USA 97, 10430-10435.
20. Kobayashi, A., Numayama-Tsuruta, K., Sogawa, K., and Fujii-Kuriyama, Y. (1997). CBP/p300 functions as a possible transcriptional coactivator of Ah receptor nuclear translocator (Arnt). J. Biochem. (Tokyo) 122, 703-710.
21. Marti, H.H., Wenger, R.H., Rivas, L.A., Straumann, U., Digicaylioglu, M., Henn, V., Yonekawa, Y., Bauer, C., and Gassmann, M. (1996). Erythropoietin gene expression in human, monkey and murine brain. Eur. J. Neurosci. 8, 666-676.
22. Miller, E.C., and Miller, J.A. (1981). Mechanisms of chemical carcinogenesis. Cancer 47, 1055-1064.
23. Nie, M., Blankenship, A.L., and Giesy, J.P. (2001). Interactions between aryl hydrocarbon receptor (AhR) and hypoxia signaling pathways. Env. Toxicol. Pharmacol. 10, 17-27.
24. Ohh, M., Park, C.W., Ivan, M., Hoffman, M.A., Kim, T.Y., Huang, L.E., Pavletich, N., Chau, V., and Kaelin, W.G. (2000). Ubiquitination of hypoxia-inducible factor requires direct binding to the β-domain of the von Hippel-Lindau protein. Nat. Cell Biol. 2, 423-427.
25. Phelan, D.M., Brackney, W.R., and Denison, M.S. (1998). The Ah receptor can bind ligand in the absence of receptor-associated heat-shock protein 90. Arch. Biochem. Biophys. 353, 47-54.
26. Phillips, D.H. (1983). Fifty years of benzo(a)pyrene. Nature 303, 468-472.
27. Pohjanvirta, R., and Tuomisto, J. (1994). Short-term toxicity of 2,3,7,8-tetrachlorodibenzo-p-dioxin in laboratory animals: effects, mechanisms, and animal models. Pharmacol. Rev. 46, 483-549.
28. Pollenz, R.S., Davarinos, N.A., and Shearer, T.P. (1999). Analysis of aryl hydrocarbon receptor-mediated signaling during physiological hypoxia reveals lack of competition for the aryl hydrocarbon nuclear translocator transcription factor. Mol. Pharmacol. 56, 1127-1137.
29. Safe, S.H. (1995). Modulation of gene expression and endocrine response pathways by 2,3,7,8-tetrachlorodibenzo-p-dioxin and related compounds. Pharmacol. Ther. 67, 247-281.
30. Salceda, S., and Caro, J. (1997). Hypoxia-inducible factor-1α (HIF-1α) protein is rapidly degraded by the ubiquitin-proteasome system under normoxic conditions. Its stabilization by hypoxia depends on redox-induced changes. J. Biol. Chem. 272, 22642-22647.
31. Semenza, G. (2002). Signal transduction to hypoxia-inducible factor 1. Biochem. Pharmacol. 64, 993-998.
32. Semenza, G.L., and Wang, G.L. (1992). A nuclear factor induced by hypoxia via de novo protein synthesis binds to the human erythropoietin gene enhancer at a site required for transcriptional activation. Mol. Cell. Biol. 12, 5447-5454.
33. Tanimoto, K., Makino, Y., Pereira, T., and Poellinger, L. (2000). Mechanism of regulation of the hypoxia-inducible factor-1α by the von Hippel-Lindau tumor suppressor protein. EMBO J. 19, 4298-4309.
34. Unkila, M., Pohjanvirta, R., Honkakoski, P., Törrönen, R., and Tuomisto, J. (1993). 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) induced ethoxyresorufin-O-deethylase (EROD) and aldehyde dehydrogenase (ALDH3) activities in the brain and liver. A comparison between the most TCDD-susceptible and the most TCDD-resistant rat strain. Biochem. Pharmacol. 46, 651-659.
35. Wang, G.L., and Semenza, G.L. (1993). Desferrioxamine induces erythropoietin gene expression and hypoxia-inducible factor 1 DNA-binding activity: implications for models of hypoxia signal transduction. Blood 82, 3610-3615.
36. Wanner, R.M., Spielmann, P., Stroka, D.M., Camenisch, G., Camenisch, I., Scheid, A., Houck, D.R., Bauer, C., Gassmann, M., and Wenger, R.H. (2000). Epolones induce erythropoietin expression via hypoxia-inducible factor-1α activation. Blood 96, 1558-1565.
37. 2-regulated gene expression. FASEB J. 16, 1151-1162.
38. Wenger, R.H., Marti, H.H., Bauer, C., and Gassmann, M. (1998). Optimal erythropoietin expression in human hepatoma cell lines requires activation of multiple signalling pathways. Int. J. Mol. Med. 2, 317-324.
39. Whitelaw, M., McGuire, J., Picard, D., Gustafsson, J., and Poellinger, L. (1995). Heat shock protein hsp90 regulates dioxin receptor function in vivo. Proc. Natl. Acad. Sci. USA 92, 4437-4441.
40. Whitlock, J.P. Jr. (1999). Induction of cytochrome P4501A1. Annu. Rev. Pharmacol. Toxicol. 39, 103-125.
41. Whitlock, J.P., Jr., Okino, S.T., Dong, L., Ko, H.P., Clarke-Katzenberg, R., Ma, Q., and Li, H. (1996). Cytochromes P450 5: induction of cytochrome P4501A1: a model for analyzing mammalian gene transcription. FASEB J. 10, 809-818.